Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02569242
Title Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Ono Pharmaceutical Co. Ltd
Indications

esophageal cancer

Therapies

Docetaxel + Paclitaxel

Nivolumab

Age Groups: adult | senior
Covered Countries USA | ITA | DEU


No variant requirements are available.